Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploration and optimisation of structure-activity relationships of new triazole-based C-terminal Hsp90 inhibitors towards in vivo anticancer potency

Published:2024-08 Issue: Volume:177 Page:116941
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Dernovšek Jaka^ORCID,Zajec Živa^ORCID,Poje Goran^ORCID,Urbančič Dunja,Sturtzel Caterina^ORCID,Goričan Tjaša,Grissenberger Sarah^ORCID,Ciura Krzesimir^ORCID,Woziński Mateusz,Gedgaudas Marius^ORCID,Zubrienė Asta,Grdadolnik Simona Golič,Mlinarič-Raščan Irena,Rajić Zrinka,Cotman Andrej Emanuel^ORCID,Zidar Nace^ORCID,Distel Martin^ORCID,Tomašič Tihomir

Funder

Narodowe Centrum Nauki

European Regional Development Fund

Agencija za raziskovalno dejavnost Republike Slovenije

OeAD

Publisher

Elsevier BV

Reference84 articles.

1. Current Cancer Epidemiology;Mattiuzzi;J. Epidemiol. Glob. Health,2019

2. Effective drug combinations in breast, colon and pancreatic cancer cells;Jaaks;Nature,2022

3. Combination therapy in combating cancer;Mokhtari;Oncotarget,2017

4. Extended Multitarget Pharmacology of Anticancer Drugs;Shi;J. Chem. Inf. Model.,2019

5. HSP90: Enabler of Cancer Adaptation;Jaeger;Annu. Rev. Cancer Biol.,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP